M&A Update – Aug 5

– STAA to be acquired by ALC for $28.00 cash per share, 51.4% premium, $1.5 billion
– YMAB to be acquired by SERB Pharmaceuticals for $8.60 cash per share, 105.3% premium, $412 million
– NVEE / TIC deal closed
– VIGL / SNY deal closed
– VRNA / MRK filed PREM14a, closing Q4 2025
– ZK / Geely Automobile Holdings filed proxy statement, vote Sept 15, closing Q4 2025